Pharmacokinetics, Efficacy, Safety, and Immunogenicity of Wilate in Previously Treated Paediatric Patients With Severe Haemophilia A

NCT03376516 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

11

Enrollment

INDUSTRY

Sponsor class

Conditions

Severe Hemophilia A

Interventions

DRUG: Wilate

Sponsor

Octapharma